ALDOA Antikörper (N-Term)
Kurzübersicht für ALDOA Antikörper (N-Term) (ABIN629801)
Target
Alle ALDOA Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- N-Term
-
Spezifität
- ALDOA antibody was raised against the N terminal of ALDOA
-
Aufreinigung
- Purified
-
Immunogen
- ALDOA antibody was raised using the N terminal of ALDOA corresponding to a region with amino acids MPYQYPALTPEQKKELSDIAHRIVAPGKGILAADESTGSIAKRLQSIGTE
-
-
-
-
Applikationshinweise
-
WB: 0.25 µg/mL
Optimal conditions should be determined by the investigator. -
Kommentare
-
ALDOA Blocking Peptide, (ABIN5612015), is also available for use as a blocking control in assays to test for specificity of this ALDOA antibody
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Lyophilized
-
Rekonstitution
- Lyophilized powder. Add distilled water for a 1 mg/mL concentration of ALDOA antibody in PBS
-
Konzentration
- Lot specific
-
Buffer
- PBS
-
Handhabung
-
Avoid repeated freeze/thaw cycles.
Dilute only prior to immediate use. -
Lagerung
- 4 °C/-20 °C
-
Informationen zur Lagerung
- Store at 2-8 °C for short periods. For longer periods of storage, store at -20 °C.
-
-
- ALDOA (Aldolase A, Fructose-Bisphosphate (ALDOA))
-
Andere Bezeichnung
- ALDOA
-
Hintergrund
- ALDOA is a glycolytic enzyme that catalyzes the reversible conversion of fructose-1,6-bisphosphate to glyceraldehyde 3-phosphate and dihydroxyacetone phosphate. Aldolase A is found in the developing embryo and is produced in even greater amounts in adult muscle. Aldolase A expression is repressed in adult liver, kidney and intestine and similar to aldolase C levels in brain and other nervous tissue. Aldolase A deficiency has been associated with myopathy and hemolytic anemia.
-
Molekulargewicht
- 39 kDa (MW of target protein)
-
Pathways
- Ribonucleoside Biosynthetic Process
Target
-